BA
ARRY

BlackRock Advisors’s Array Biopharma Inc ARRY Stock Holding History

BlackRock Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$790K Buy
89,909
+16,073
+22% +$118K ﹤0.01% 1970
2016
Q3 		$498K Buy
73,836
+4,421
+6% +$17.1K ﹤0.01% 2176
2016
Q2 		$247K Sell
69,415
-123,920
-64% -$404K ﹤0.01% 2490
2016
Q1 		$570K Buy
193,335
+5,814
+3% +$17.4K ﹤0.01% 2011
2015
Q4 		$791K Sell
187,521
-32,858
-15% -$150K ﹤0.01% 1840
2015
Q3 		$1M Buy
220,379
+92,014
+72% +$546K ﹤0.01% 1686
2015
Q2 		$926K Buy
128,365
+39,595
+45% +$292K ﹤0.01% 1719
2015
Q1 		$654K Sell
88,770
-1,162,081
-93% -$8.27M ﹤0.01% 1878
2014
Q4 		$5.92M Sell
1,250,851
-8,325
-0.7% -$32.9K 0.01% 926
2014
Q3 		$4.5M Sell
1,259,176
-122,168
-9% -$482K ﹤0.01% 997
2014
Q2 		$6.3M Sell
1,381,344
-328,920
-19% -$1.36M 0.01% 910
2014
Q1 		$8.04M Buy
1,710,264
+5,761
+0.3% +$29K 0.01% 860
2013
Q4 		$8.54M Sell
1,704,503
-284,232
-14% -$1.55M 0.01% 838
2013
Q3 		$12.4M Buy
1,988,735
+1,917,493
+2,692% +$11.4M 0.01% 714
2013
Q2 		$323K Buy
+71,242
New +$383K ﹤0.01% 2154

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BlackRock Advisors's ARRY Position: Q4 2016 in Review

BlackRock Advisors increased its Array Biopharma Inc (ARRY) stake by 22% in Q4 2016, buying an estimated $118K and bringing the position to 89,909 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

BlackRock Advisors first reported a position in ARRY in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.4M in Q3 2013. 167 funds tracked by Wall St. Rank hold ARRY as of Q4 2016.

  • BlackRock Advisors held 89,909 shares of Array Biopharma Inc worth $790K as of Q4 2016.
  • BlackRock Advisors bought 16,073 Array Biopharma Inc shares in Q4 2016, an estimated $118K.
  • Array Biopharma Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1970 holding.
  • BlackRock Advisors first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Array Biopharma Inc position peaked at $12.4M in Q3 2013.
  • 167 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.